Advertisement

Topics

Press Releases about Biotechnology, Pharmaceutical and Healthcare

04:57 EST 19th November 2018 | BioPortfolio

Latest biotech, pharma, healthcare and medical device news.

Showing News Articles 1–25 of 52,000+

Monday 19th November 2018

RF Safe Public Awareness Campaign: Study Shows Smartphone Radiation Triggers Memory Loss In Right-handed Teenagers

According to RF Safe, "Smartphone radiation could be destroying the memory performance of a new generation of adolescents. Right-handed teens using cell phones are more prone to loss of figural memory which is mainly located in the right hemisphere of the brain and refers to our ability to make sense of objects including images, patterns, and shapes a troubling new study has warned." PHO...

SANYEI CORPORATION Based in Japan Launches ION-Sei™ into the UK Market in Time for the Christmas Season. A Unique Electric Toothbrush That Uses Patented Technology to Suppress Bacteria That Cause Plaque and Gum Disease

Patented innovative and unique technology, that works by using UV light, a Titanium Dioxide (TiO2) rod, Water, generating electrons and ions, creating a longer lasting, deeper clean Japanese Technology combined with contemporary German Design, creates an elegant but functional electric toothbrush Very effective,...

APEC's Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by 2025

Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). Aims to define, diagnose and support rare disease patients through innovation, education, building capacity and aligning policies across the 21 APEC member...

Active Biotech's election committee appointed

PRESS RELEASE In accordance with a decision made by the Annual General Meeting held on May 17, 2018, the Election Committee shall comprise the representatives for the three largest shareholders by votes, as per end of September 2018, and the Chairman of the Board. For the 2019 Annual General Meeting, the Election Committee shall propose Board members and a Chairman of the Boa...

Warm Temps at Winter’s Peak Only Part of Package for 2019 iaedp™ Symposium

The International Association of Eating Disorders Professionals (iaedp™) Foundation will hold its 33rd annual Symposium at the JW Marriott Desert Springs Resort during February 7 – 10, 2019. PEKIN, Ill. (PRWEB) November 19, 2018 The International Association of Eating Disorders Professionals (iaedp™) Foundation will hold its 33rd annual Symposium at the JW Marriott Desert Springs Resort dur...

Good Leads® Extends the "End of Year" Incentive Plan for Outsourced B2B Lead Generation Services

Good Leads® is extending the "EOY” incentive plan with a 2 month offering and financing for outsourced B2B Lead Generation services. Good Leads will rapidly deploy a Strategic Strike inside sales team under their Prospect Builder® Program and extend delayed payments till the end of the contract term in 2019. SALEM, N.H. (PRWEB) November 19, 2018 Good Leads® is extending the ...

Forbion Leads €40m Series B Financing in Inflazome to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept

Funding to advance clinical trials of Inflazome’s pioneering orally-available NLRP3 inflammasome inhibitor compounds in several chronic inflammatory diseases NLRP3 is associated with harmful inflammation in a broad range of serious medical conditions including Alzheimer’s, Parkinson’s, inflammatory bowel disease, gout,...

GENFIT ANNOUNCES PLANS TO CONDUCT REGISTERED PUBLIC OFFERING IN THE UNITED STATES

FOR IMMEDIATE RELEASE GENFIT ANNOUNCES PLANS TO CONDUCT REGISTERED PUBLIC OFFERING IN THE UNITED STATES Lille (France), Cambridge (Massachusetts, United States), November 19, 2018 - GENFIT SA (Euronext: GNFT), a French biopharmaceutical company focused on discovering and developing drug candidates and diagnostic solutions targeting liver diseases, in particular those of metabo...

Inflazome Completes €40m ($46m) Series B Financing to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept

Financing led by Forbion, with Longitude Capital and founding investors, Novartis Venture Fund and Fountain Healthcare Partners, also participating Funding to advance clinical trials of Inflazome’s pioneering orally-available NLRP3 inflammasome inhibitor compounds in several inflammatory diseases NLRP...

Bridge Biotherapeutics Files Investigational New Drug Application for BBT-877, an Autotaxin Inhibitor for Idiopathic Pulmonary Fibrosis

The first-in-human study will be initiated early next year Orphan Drug Designation application was filed for IPF SEONGNAM, South Korea, Nov. 18, 2018 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant company of JLABS@TMC in Houston, Texas, announced that the company filed an Investigational New Drug (IND) appl...

Biosense Webster Launches Report - The Burden of Atrial Fibrillation: Understanding the Impact of the New Millennium Epidemic Across Europe

New report released during AF Association Global AF Aware Week highlights AF as one of the world’s most significant health issues Shows need for greater awareness of AF and its impact on patients and on healthcare systems across Europe By 2030 the number of people with AF is projected to increase by up to 70%1...

Sunday 18th November 2018

China National Medical Products Administration (NMPA) Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for Chronic Hepatitis B Virus (HBV) Infection

- First New Oral Treatment Approved for HBV in Ten Years Offers Improved Renal and Bone Laboratory Safety Parameters Compared to Tenofovir Disoproxil Fumarate (TDF) – Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the China National Medical Products Administration (NMPA) has approved Vemlidy® (tenofovir alafenamide, TAF) 25 mg, a once-dai...

Celltrion Healthcare: Biosimilars Have the Potential to Deliver Dramatic Cost Savings for US and European Healthcare Systems

As the global leader in biosimilars, Celltrion Healthcare aims to positively shape future healthcare by improving patient access to biosimilars Celltrion Healthcare outlined their vision of ‘shaping future healthcare by improving access to biosimilars’ at the 5th Annual Biosimilars USA Conference in New Jersey, US. Biosimilars offer...

Landmark PALISADE Trial of AR101 Published in New England Journal of Medicine

— Treatment with AR101 significantly increased the amount of peanut protein tolerated and reduced the number and severity of reactions to peanut protein — — Aimmune conference call Monday, November 19 at 8:00 a.m. Eastern — Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for potentially life-...

RF Safe Rebuttal: American Cancer Society Cell Phone Brain Tumor Comments By Dr. Otis W. Brawley

There has been significant coverage in the media on comments made by Dr. Otis Brawley, the chief medical officer of the American Cancer Society who resigned from an 11 year career after wrongfully downplaying a critical new scientific consensus which concludes that the U.S. National Toxicology Program (NTP) study has found “clear evidence” that cell phone level radiation does cause cancer. DET...

"A Breath of Hope" Bubble Cruise Carnival Raises Funds to Support Lung Cancer Patients

Campaign attempted a Guinness World Records title for the Largest Soap Bubble Making Lesson to Mark Lung Cancer Awareness Month HONG KONG, Nov. 18, 2018 /PRNewswire/ -- To mark Lung Cancer Awareness Month, "A Breath of Hope" Campaign and the Hong Kong Lung Cancer Study Group (HKLCSG) hosted their first Bubble Cruise Carnival to raise awareness of lung cancer, provide important informati...

Stanford Neuroscientist Karl Deisseroth Receives Japan’s Kyoto Prize in Advanced Technology

Revolutionary discoveries bring award of 100 million yen (about US$880,000) The Inamori Foundation today announced that it has presented its 34th annual Kyoto Prize in Advanced Technology to Dr. Ka

Saturday 17th November 2018

This #AmericanDiabetesMonth, we’re showcasing the #EverydayReality of living with type 2 diabetes. Check out this story from Jerry, and visit http://bit.ly/1WYApqm  to join the conversation!pic.twitter.com/gBT20dcXzp

This #AmericanDiabetesMonth, we’re showcasing the #EverydayReality of living with type 2 diabetes. Check out this story from Jerry, and visit http://bit.ly/1WYApqm  to join the conversation! pic.twitter.com/gBT20dcXzp

HCCN President Presented with Doctorate from Academy of Holistic Theology & Spirituality

Organizations Committed to Highest of Standards and Quality in Patient Spiritual Care NEW YORK (PRWEB) November 17, 2018 The Academy of Holistic Theology & Spirituality presented the Rev. Eric J. Hall, M.A., M.Div. with a Doctor of Theology degree in Chaplaincy for his academic contributions to the field of spiritual care and the profession of chaplaincy. The honor came at HealthCare Chaplai...

We are excited to announce the launch of the Building Block Exchange, in collaboration with @JanssenUS, to share chemical materials for potentially faster innovation: https://on.pfizer.com/2DJ7eF8 pic.twitter.com/WXpz4VwuX5

We are excited to announce the launch of the Building Block Exchange, in collaboration with @JanssenUS, to share chemical materials for potentially faster innovation: https://on.pfizer.com/2DJ7eF8  pic.twitter.com/WXpz4VwuX5

The Premiere of Your Life by Design Podcast with Dr. Sundardas D. Annamalay - Win a Private Consultation with Dr. Sundardas

Multiple award-winning entrepreneur, best-selling author, professor of natural medicine, and naturopathic physician, Dr. Sundardas D. Annamalay (Dr. Sun) premieres his brand new podcast, Your Life by Design. Plus one lucky listener each week, who posts a review on iTunes, will win a private transformational consultation with Dr. Sundardas to discover his/her unique soul purpose. SINGAPORE (PRWEB) ...

Supported by @AstraZeneca hear leading speakers discuss the use of #CRISPR libraries to identify novel drug targets and identify new disease mechanisms. Functional Genomics will help understand disease and discover new medicines @SCICambridge @Cambridge_

Supported by @AstraZeneca hear leading speakers discuss the use of #CRISPR libraries to identify novel drug targets and identify new disease mechanisms. Functional Genomics will help understand disease and discover new medicines @SCICambridge @Cambridge_Uni @OneNucleus

Laurence Fishburne to Host an Upcoming "Information Matrix" Segment on Trauma Treatment

A new segment looks into the growing practice of treating mental trauma. MIAMI (PRWEB) November 17, 2018 Laurence Fishburne – award-winning actor and renowned writer and producer – hosts “Information Matrix.” This educational and informative television series highlight the evolution of medicine, education, industry, technology, and science through the use of inspirational personal stories...

Friday 16th November 2018

Doctor On Demand Encourages All California Residents Impacted by Poor Air Quality to Stay Inside

Leading Virtual Care Provider to Cover Video Visits for all Those Affected by California Wildfires The California wildfires are not just affecting those directly in their path, but affecting millions of residents who are now breathing in the hazardous air conditions. Doctor On Demand, the nation’s leading virtual care provider, is encouraging ...

Women’s Excellence in Rochester, Michigan Now Offers Treatment Plans for Women with Pelvic Pain

Women's Excellence specializes in the diagnosis and treatment of chronic pelvic pain. ROCHESTER, Mich. (PRWEB) November 16, 2018 Women’s Excellence in Rochester, Michigan, will now offer treatment options to patients suffering from chronic pelvic pain. In addition to oncology services, the new center will specialize in the diagnosis and treatment of various pelvic pain disorders including e...


Advertisement
Quick Search
Advertisement
Advertisement